Alternatives to NanoStruct

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Developing novel immunotherapies and diagnostics for cancer.

Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.

Revolutionizing genomic analysis with innovative sequencing technology.

Europe's first cultivated meat company, focused on scalable and affordable production.

Developing breath-based diagnostics for lung diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Millow is a Swedish foodtech company that develops and produces mycelium-based protein ingredients for the B2B foodservice and retail markets.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A vertically-integrated procurement platform for the life sciences industry.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Ensilitech develops innovative solutions for the detection and analysis of foodborne pathogens and contaminants.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A global leader in clinical pharmacology and bioanalytical sciences.